Back to search
Colorectal Adenocarcinoma Metastatic in the Liver
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal Adenocarcinoma Metastatic in the Liver trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal Adenocarcinoma Metastatic in the Liver trials you may qualify forBackground: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding the…
This study is an open-label Phase Ib (Part A) dose escalation followed by a blinded, randomized, multi cohort Phase 2a (Part B) comparison of combination vs. re…
The purpose of this study is to study the way radioembolization works by collecting biopsy samples of participants' tumors after the procedure. This research ma…
This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary…
This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid t…
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck s…
The aim of this study is to validate a proposed classification system regarding overall survival as well as a comparison with patients with liver metastases and…
The purpose of this research study is: * To find out how safe the study drug, pembrolizumab, is when combined with stereotactic body radiotherapy (SBRT) to the…